La Jolla Labs has built a cloud-based tool to enable researchers anywhere to design and execute large in vitro drug screens for RNA-targeting compounds. This software platform is capable of generating pools of drug candidates, greatly increasing the chances of preclinical and clinical success. For the first time this complex and cost-prohibitive assay is accessible to all research programs, including start-ups and academic laboratories.